Telescope Therapeutics is interested in impacting cardiac fibrosis, a key driver of heart failure using a human disease relevant model derived from iPSCs combined with sophisticated biosensor-based phenotypic evaluation. This approach enables real-time testing of drug candidates at the cellular level, providing insights into therapeutic potential. Our goal is to discover and develop treatments for fibrosis for heart disease and ultimately other indications.
Company Details
- Employees
- 6
- Founded
- -
- Address
- 7171 Rue Frederick-Banting, Montreal,quebec H4s 1z9,canada
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- providers..
- HQ
- Montreal, Quebec
Telescope Therapeutics Questions
Telescope Therapeutics's website is https://www.telescopetherapeutics.com/
Telescope Therapeutics's LinkedIn profile is https://ca.linkedin.com/company/telescopetherapeutics
Telescope Therapeutics has
6 employees.
View email and phone details for 6
employees at Telescope Therapeutics.
Telescope Therapeutics's industry is
Biotechnology Research
Telescope Therapeutics's top competitors are
Targa Biomedical,
Mitacs,
Epiloid Biotechnology,
Feldan Therapeutics ǀ Feldan Thérapeutiques,
Admare Bioinnovations,
Axolotl Biosciences,
Mediphage,
Mesintel Therapeutics,
Cellect Laboratories,
Stem Cell Network.
Telescope Therapeutics's categories are Biotechnology Research
Telescope Therapeutics's founding year is 2024
